Scilex Holding Company revenue for the last year amounted to 46.74 M USD, the most of which — 46.74 M USD — came from its highest performing source at the moment, Non-Opioid Pain Management Products, the year earlier bringing 38.03 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Scilex Holding Company 46.74 M USD, and the year before that — 38.03 M USD.